Birch K A, Pober J S, Zavoico G B, Means A R, Ewenstein B M
Department of Microbiology, Biological Chemistry, and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115.
J Cell Biol. 1992 Sep;118(6):1501-10. doi: 10.1083/jcb.118.6.1501.
Thrombin stimulates cultured endothelial cells (EC) to secrete stored von Willebrand factor (vWF), but the signal transduction pathways are poorly defined. Thrombin is known to elevate the concentration of intracellular calcium ([Ca2+]i) and to activate protein kinase C (PKC) in EC. Since both calcium ionophores and phorbol esters release vWF, both second messenger pathways have been postulated to participate in vWF secretion in response to naturally occurring agonists. We find that in intact human EC, vWF secretion stimulated by either thrombin or by a thrombin receptor activating peptide, TR(42-55), can be correlated with agonist-induced elevations of [Ca2+]i. Further evidence implicating calcium in the signal transduction pathway is suggested by the finding that MAPTAM, a cell-permeant calcium chelator, in combination with the extracellular calcium chelator EGTA, can inhibit thrombin-stimulated secretion. In contrast, the observation that staurosporine (a pharmacological inhibitor of PKC) blocks phorbol ester- but not thrombin-stimulated secretion provides evidence against PKC-mediated signal transduction. To examine further the signal transduction pathway initiated by thrombin, we developed novel conditions for minimal permeabilization of EC with saponin (4-8 micrograms/ml for 5-15 min at 37 degrees C) which allow the introduction of small extracellular molecules without the loss of large intracellular proteins and which retain thrombin-stimulated secretion. These minimally permeabilized cells secrete vWF in response to exogenous calcium, and EGTA blocks thrombin-induced secretion. Moreover, in these cells, thrombin-stimulated secretion is blocked by a calmodulin-binding inhibitory peptide but not by a PKC inhibitory peptide. Taken together, these findings demonstrate that thrombin-stimulated vWF secretion is transduced by a rise in [Ca2+]i and provide the first evidence for the role of calmodulin in this process.
凝血酶刺激培养的内皮细胞(EC)分泌储存的血管性血友病因子(vWF),但其信号转导途径尚不清楚。已知凝血酶可提高细胞内钙浓度([Ca2+]i)并激活内皮细胞中的蛋白激酶C(PKC)。由于钙离子载体和佛波酯均可释放vWF,因此推测这两种第二信使途径均参与了对天然激动剂的反应中vWF的分泌。我们发现,在完整的人内皮细胞中,凝血酶或凝血酶受体激活肽TR(42-55)刺激的vWF分泌与激动剂诱导的[Ca2+]i升高相关。细胞可渗透的钙螯合剂MAPTAM与细胞外钙螯合剂EGTA联合使用可抑制凝血酶刺激的分泌,这一发现进一步证明了钙参与信号转导途径。相反,星形孢菌素(PKC的药理学抑制剂)可阻断佛波酯而非凝血酶刺激的分泌,这一观察结果提供了反对PKC介导信号转导的证据。为了进一步研究凝血酶引发的信号转导途径,我们开发了新的条件,即用皂角苷(4-8微克/毫升,在37℃下作用5-15分钟)使内皮细胞最小程度通透,这样可引入小的细胞外分子而不损失大的细胞内蛋白质,并保留凝血酶刺激的分泌。这些最小程度通透的细胞对外源钙分泌vWF,EGTA可阻断凝血酶诱导的分泌。此外,在这些细胞中,凝血酶刺激的分泌被钙调蛋白结合抑制肽阻断,而未被PKC抑制肽阻断。综上所述,这些发现表明凝血酶刺激的vWF分泌是由[Ca2+]i升高介导的,并首次证明了钙调蛋白在此过程中的作用。